Nature Reviews Urology

EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience

Retrieved on: 
Lundi, avril 10, 2023
Abstract, The New England Journal of Medicine, Katherine, Assistant professor, High, Intensity, University, Prostate cancer, High-intensity focused ultrasound, Teaching, 3D, EDAP, JAMA Surgery, PDT, Keck School of Medicine of USC, Research, Prostate, Nature Reviews Urology, EDT, Bangladesh Technical Education Board, National Cancer Institute, MRI, USC Institute of Armenian Studies, Magnetic resonance imaging, MD, Patient, Physician, Webcast, Cancer, Kidney, Health, Distinguishing, Medical imaging, Nursing, Medical device, European Urology, Cryoablation, USC, Urology

LYON, France, April 10, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today announced that the Company will host a webcast that will feature a live procedure broadcast of its Focal One HIFU as a potential treatment for ablating cancer tissue in patients who are diagnosed with prostate cancer. The webcast is scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT).

Key Points: 
  • The procedure will be performed by Andre Abreu, MD and Amir H. Lebastchi, MD, Assistant Professors of Clinical Urology at Keck Medicine of the University of Southern California (USC).
  • Teaching and sharing best practices in new clinical treatments are critical to ensuring more patients can avail themselves of the latest technologies with the absolute best results.
  • Andre Luis de Castro Abreu, MD has expertise in MRI/TRUS fusion prostate biopsy and focal therapy, including High Intensity Focused Ultrasound (HIFU) and Cryoablation, for prostate cancer.
  • He also specialized in focal therapy for prostate cancer, including noninvasive techniques such as High Intensity Focused Ultrasound (HIFU) and cryoablation.

Affluent Medical : Financial results for the first half of 2021 and main clinical update.

Retrieved on: 
Mercredi, septembre 22, 2021
ESC, Man, Review, American College of Cardiology, Feedback, FCCP, Death, University, Icahn School of Medicine at Mount Sinai, Silver, Cotignola, Degenerative disease, University of Paris, Mitral valve, FAHA, Heart, Neuro, Group, Education, Committee, Journal, IFRS, Andreas, Cardiovascular disease, Urinary incontinence, EAU, Professor, Company, FESC, Health policy, BJU International, Kalio, Mehran, SAIME, NYHA, The Journal of Urology, Surgeon, COVID-19, Patient, FACC, FACP, American College, Ethics, Adrenal insufficiency, Nature Reviews Urology, Trial of the century, Mount Sinai Hospital, IPO, European Urology, Artus, Animal, Security (finance), Medical device, Pharmaceutical industry, Medicine

During the first half of 2021, purchases consumed fell by 158 thousand compared to the first half of 2020.

Key Points: 
  • During the first half of 2021, purchases consumed fell by 158 thousand compared to the first half of 2020.
  • On 9 June 2021, Affluent Medical announced the success of its IPO on the regulated market of Euronext Paris.
  • Starting in 2018 he broadened his field of expertise by engaging in various entrepreneurial projects before joining Affluent Medical.
  • Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas.